Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands.

Tomizawa, Yuji; Hoshino, Yasunobu; Kamo, Ryota; Cossu, Davide; Yokoyama, Kazumasa; Hattori, Nobutaka

Tomizawa, Yuji; Hoshino, Yasunobu; Kamo, Ryota; Cossu, Davide; Yokoyama, Kazumasa; Hattori, Nobutaka.

Afiliação

Tomizawa Y; Department of Neurology, School of Medicine, Juntendo University, Tokyo, Japan.
Hoshino Y; Department of Neurology, School of Medicine, Juntendo University, Tokyo, Japan.
Kamo R; Department of Neurology, School of Medicine, Juntendo University, Tokyo, Japan.
Cossu D; Department of Neurology, School of Medicine, Juntendo University, Tokyo, Japan.
Yokoyama K; Department of Biomedical Sciences, Sassari University, Sassari, Italy.
Hattori N; Department of Neurology, School of Medicine, Juntendo University, Tokyo, Japan.

Front Immunol ; 14: 1211776, 2023.

Article em En | MEDLINE | ID: mdl-37520579

Assuntos

Sistema Nervoso Central; Bandas Oligoclonais; Humanos; Glicoproteína Mielina-Oligodendrócito; Doença Crônica; Imunoglobulina G

Palavras-chave

IgG index; multiple sclerosis; myelin oligodendrocyte glycoprotein antibody-associated disease; oligoclonal bands; relapse rate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google